Physiomics plc (LSE:PYC) has taken a strategic step forward with the appointment of Jesse Thissen as its new Head of Biometrics and the signing of two initial contracts in this service area. The contracts, worth a combined £111,000, have been secured with a UK-based biopharma company and will see Physiomics deliver biostatistical consulting and statistical programming to support clinical development efforts.
Mr. Thissen brings extensive expertise in biostatistics and is expected to play a key role in driving the growth of Physiomics’ biometrics division. This addition complements the company’s established strengths in modelling and simulation, enabling the company to offer a more comprehensive suite of services to biotech and pharmaceutical clients.
By expanding into biometrics, Physiomics aims to strengthen its competitive positioning and accelerate its ability to scale service delivery across a broader range of clinical programs. The move supports the company’s long-term objective of becoming a fully integrated provider of analytical solutions in drug development.
About Physiomics
Physiomics plc is a UK-based technology-driven consultancy specializing in data science, mathematical modelling, and biostatistics for the pharmaceutical and biotech industries. The company supports clients in optimizing drug development through its expertise in Modelling & Simulation, Bioinformatics, and its proprietary Virtual Tumour™ platform. Physiomics has worked with prominent clients including Merck KGaA, Bicycle Therapeutics, and Astellas.
Leave a Reply